Intermittent Preventive Treatment against Malaria in Infants in Gabon—A Randomized, Double‐Blind, Placebo‐Controlled Trial | Zendy

Martin P. Grobusch | Zendy; Bertrand Lell | Zendy; Norbert Georg Schwarz | Zendy; Julian Gabor | Zendy; Jenny Dörnemann | Zendy; Marc Pötschke | Zendy; Sunny Oyakhirome | Zendy; Georg Kießling | Zendy; Magdaleecek | Zendy; Matthias Längin | Zendy; Peter Klein Klouwenberg | Zendy; Anna Klöpfer | Zendy; Benjamin Naumann | Zendy; Handan Altun | Zendy; Selidji Todagbé Agnandji | Zendy; Julia Goesch | Zendy; Marie-Luise Decker | Zendy; Carmen L. Ospina Salazar | Zendy; Christian Supan | Zendy; Davy U. Kombila | Zendy; Lea B. Borchert | Zendy; Kai B. Köster | Zendy; Peter Pongratz | Zendy; Ayôla Akim Adégnika | Zendy; I. v. Glasenapp | Zendy; Saadou Issifou | Zendy; Peter G. Kremsner | Zendy

Open Access

Intermittent Preventive Treatment against Malaria in Infants in Gabon—A Randomized, Double‐Blind, Placebo‐Controlled Trial

Author(s) -

Martin P. Grobusch,

Bertrand Lell,

Norbert Georg Schwarz,

Julian Gabor,

Jenny Dörnemann,

Marc Pötschke,

Sunny Oyakhirome,

Georg Kießling,

Magdaleecek,

Matthias Längin,

Peter Klein Klouwenberg,

Anna Klöpfer,

Benjamin Naumann,

Handan Altun,

Selidji Todagbé Agnandji,

Julia Goesch,

Marie-Luise Decker,

Carmen L. Ospina Salazar,

Christian Supan,

Davy U. Kombila,

Lea B. Borchert,

Kai B. Köster,

Peter Pongratz,

Ayôla Akim Adégnika,

I. v. Glasenapp,

Saadou Issifou,

Peter G. Kremsner

Publication year - 2007

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/522160

Subject(s) - medicine , chemoprophylaxis , placebo , malaria , sulfadoxine , anemia , sulfadoxine/pyrimethamine , randomized controlled trial , population , pediatrics , confidence interval , pyrimethamine , chloroquine , immunology , alternative medicine , environmental health , pathology

Intermittent preventive treatment aims to maximize the protective effects of malaria chemoprophylaxis while minimizing the deleterious effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research